Fluorescence in situ hybridization: Uses and limitations
- 1 October 2000
- journal article
- review article
- Published by Elsevier BV in Seminars in Hematology
- Vol. 37 (4), 320-333
- https://doi.org/10.1016/s0037-1963(00)90013-1
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Monosomy 13 Is Associated With the Transition of Monoclonal Gammopathy of Undetermined Significance to Multiple MyelomaBlood, 1999
- High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridizationGenes, Chromosomes and Cancer, 1999
- Fish Analysis at Diagnosis in Acute Lymphoblastic LeukemiaLeukemia & Lymphoma, 1999
- Total Therapy With Tandem Transplants for Newly Diagnosed Multiple MyelomaBlood, 1999
- Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3Nature Genetics, 1997
- Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlationsGenes, Chromosomes and Cancer, 1997
- A complete set of human telomeric probes and their clinical applicationNature Genetics, 1996
- Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridizationBlood, 1994
- Detection of trisomy 12 in chronic lymphocytic leukemia by fluorescence in situ hybridization to interphase cells: a simple and sensitive methodBlood, 1992
- Detection of chromosome aberrations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probesHuman Genetics, 1988